Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.

Merante S, Ferretti VV, Elena C, Brazzelli V, Zanotti R, Ner I, Magliacane D, Belloni Fortina A, Ingeborg F, Pastorello EA, Pieri L, Papayannidis C, Mauro M, Grifoni F, Minelli R, Guggiari E, Difonzo E, Bocchia M, Caroppo F, Di Nuzzo S, Elli EM, Rondoni M, Ciccocioppo R, Stefano MD, Bossi G, Boveri E, Bonadonna P, Giona F, Valent P, Triggiani M.

Future Oncol. 2018 Sep 12. doi: 10.2217/fon-2018-0291. [Epub ahead of print]

PMID:
30207489
2.

Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.

Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, Nezi L, Corti D, Minelli R, Pettazzoni P, Gutschner T, Wu CC, Seth S, Akdemir KC, Leo E, Amin S, Molin MD, Ying H, Kwong LN, Colla S, Takahashi K, Ghosh P, Giuliani V, Muller F, Dey P, Jiang S, Garvey J, Liu CG, Zhang J, Heffernan TP, Toniatti C, Fleming JB, Goggins MG, Wood LD, Sgambato A, Agaimy A, Maitra A, Roberts CW, Wang H, Viale A, DePinho RA, Draetta GF, Chin L.

Nature. 2017 Feb 16;542(7641):362-366. doi: 10.1038/nature21064. Epub 2017 Feb 8.

PMID:
28178232
3.

In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.

Gigliotti CL, Minelli R, Cavalli R, Occhipinti S, Barrera G, Pizzimenti S, Cappellano G, Boggio E, Conti L, Fantozzi R, Giovarelli M, Trotta F, Dianzani U, Dianzani C.

J Biomed Nanotechnol. 2016 Jan;12(1):114-27.

PMID:
27301177
4.

Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.

German P, Bai S, Liu XD, Sun M, Zhou L, Kalra S, Zhang X, Minelli R, Scott KL, Mills GB, Jonasch E, Ding Z.

Oncogene. 2016 Sep 22;35(38):4973-80. doi: 10.1038/onc.2016.40. Epub 2016 Mar 14.

5.

Functional annotation of rare gene aberration drivers of pancreatic cancer.

Tsang YH, Dogruluk T, Tedeschi PM, Wardwell-Ozgo J, Lu H, Espitia M, Nair N, Minelli R, Chong Z, Chen F, Chang QE, Dennison JB, Dogruluk A, Li M, Ying H, Bertino JR, Gingras MC, Ittmann M, Kerrigan J, Chen K, Creighton CJ, Eterovic K, Mills GB, Scott KL.

Nat Commun. 2016 Jan 25;7:10500. doi: 10.1038/ncomms10500.

6.

Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models.

Pizzimenti S, Daga M, Ciamporcero E, Toaldo C, Pettazzoni P, Osella-Abate S, Novelli M, Minelli R, Bisazza A, Gamba P, Testa G, Ullio C, Ferruti P, Ranucci E, Bernengo MG, Ferretti C, Dianzani C, Biasi F, Barrera G, Cavalli R.

J Biomed Nanotechnol. 2015 Dec;11(12):2169-85.

PMID:
26510311
7.

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

Han L, Diao L, Yu S, Xu X, Li J, Zhang R, Yang Y, Werner HMJ, Eterovic AK, Yuan Y, Li J, Nair N, Minelli R, Tsang YH, Cheung LWT, Jeong KJ, Roszik J, Ju Z, Woodman SE, Lu Y, Scott KL, Li JB, Mills GB, Liang H.

Cancer Cell. 2015 Oct 12;28(4):515-528. doi: 10.1016/j.ccell.2015.08.013. Epub 2015 Oct 1.

8.

Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.

Pettazzoni P, Viale A, Shah P, Carugo A, Ying H, Wang H, Genovese G, Seth S, Minelli R, Green T, Huang-Hobbs E, Corti D, Sanchez N, Nezi L, Marchesini M, Kapoor A, Yao W, Francesco ME, Petrocchi A, Deem AK, Scott K, Colla S, Mills GB, Fleming JB, Heffernan TP, Jones P, Toniatti C, DePinho RA, Draetta GF.

Cancer Res. 2015 Mar 15;75(6):1091-101. doi: 10.1158/0008-5472.CAN-14-1854. Epub 2015 Mar 3.

9.

Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma.

Chen Y, Terajima M, Yang Y, Sun L, Ahn YH, Pankova D, Puperi DS, Watanabe T, Kim MP, Blackmon SH, Rodriguez J, Liu H, Behrens C, Wistuba II, Minelli R, Scott KL, Sanchez-Adams J, Guilak F, Pati D, Thilaganathan N, Burns AR, Creighton CJ, Martinez ED, Zal T, Grande-Allen KJ, Yamauchi M, Kurie JM.

J Clin Invest. 2015 Mar 2;125(3):1147-62. doi: 10.1172/JCI74725. Epub 2015 Feb 9.

10.

B7h triggering inhibits the migration of tumor cell lines.

Dianzani C, Minelli R, Gigliotti CL, Occhipinti S, Giovarelli M, Conti L, Boggio E, Shivakumar Y, Baldanzi G, Malacarne V, Orilieri E, Cappellano G, Fantozzi R, Sblattero D, Yagi J, Rojo JM, Chiocchetti A, Dianzani U.

J Immunol. 2014 May 15;192(10):4921-31. doi: 10.4049/jimmunol.1300587. Epub 2014 Apr 11.

11.

New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studies.

Cavalli R, Leone F, Minelli R, Fantozzi R, Dianzani C.

Curr Drug Deliv. 2014;11(2):270-8.

12.

Course of graves disease in interferon-treated patients with chronic hepatitis C virus infection and in uninfected patients.

Minelli R, Spagnoli F, Marchesi E, Venturi N, Marina M, Orlandini A, Zardo M, Ferrari C, Ceresini G.

J Investig Med. 2013 Dec;61(8):1173-7. doi: 10.2310/JIM.0000000000000000.

PMID:
24113731
13.

Interaction of aldehydes derived from lipid peroxidation and membrane proteins.

Pizzimenti S, Ciamporcero E, Daga M, Pettazzoni P, Arcaro A, Cetrangolo G, Minelli R, Dianzani C, Lepore A, Gentile F, Barrera G.

Front Physiol. 2013 Sep 4;4:242. doi: 10.3389/fphys.2013.00242. Review.

14.

The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model.

Pizzimenti S, Ciamporcero E, Pettazzoni P, Osella-Abate S, Novelli M, Toaldo C, Husse M, Daga M, Minelli R, Bisazza A, Ferruti P, Ranucci E, Grazia Bernengo M, Dianzani C, Biasi F, Cavalli R, Barrera G.

Free Radic Biol Med. 2013 Dec;65:765-777. doi: 10.1016/j.freeradbiomed.2013.06.035. Epub 2013 Jun 26.

15.

Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.

Minelli R, Occhipinti S, Gigliotti CL, Barrera G, Gasco P, Conti L, Chiocchetti A, Zara GP, Fantozzi R, Giovarelli M, Dianzani U, Dianzani C.

Br J Pharmacol. 2013 Sep;170(2):233-44. doi: 10.1111/bph.12255.

16.

Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells.

Occhipinti S, Dianzani C, Chiocchetti A, Boggio E, Clemente N, Gigliotti CL, Soluri MF, Minelli R, Fantozzi R, Yagi J, Rojo JM, Sblattero D, Giovarelli M, Dianzani U.

J Immunol. 2013 Feb 1;190(3):1125-34. doi: 10.4049/jimmunol.1201816. Epub 2012 Dec 28.

17.

Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.

Minelli R, Cavalli R, Ellis L, Pettazzoni P, Trotta F, Ciamporcero E, Barrera G, Fantozzi R, Dianzani C, Pili R.

Eur J Pharm Sci. 2012 Nov 20;47(4):686-94. doi: 10.1016/j.ejps.2012.08.003. Epub 2012 Aug 15.

18.

Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells.

Cerbone A, Toaldo C, Minelli R, Ciamporcero E, Pizzimenti S, Pettazzoni P, Roma G, Dianzani MU, Ullio C, Ferretti C, Dianzani C, Barrera G.

PLoS One. 2012;7(6):e40149. doi: 10.1371/journal.pone.0040149. Epub 2012 Jun 28.

19.

AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.

Cerbone A, Toaldo C, Pizzimenti S, Pettazzoni P, Dianzani C, Minelli R, Ciamporcero E, Roma G, Dianzani MU, Canaparo R, Ferretti C, Barrera G.

PPAR Res. 2012;2012:269751. doi: 10.1155/2012/269751. Epub 2012 Feb 29.

20.

Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.

Minelli R, Serpe L, Pettazzoni P, Minero V, Barrera G, Gigliotti C, Mesturini R, Rosa AC, Gasco P, Vivenza N, Muntoni E, Fantozzi R, Dianzani U, Zara GP, Dianzani C.

Br J Pharmacol. 2012 May;166(2):587-601. doi: 10.1111/j.1476-5381.2011.01768.x.

21.

Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells.

Pettazzoni P, Ciamporcero E, Medana C, Pizzimenti S, Dal Bello F, Minero VG, Toaldo C, Minelli R, Uchida K, Dianzani MU, Pili R, Barrera G.

Free Radic Biol Med. 2011 Oct 15;51(8):1610-8. doi: 10.1016/j.freeradbiomed.2011.07.009. Epub 2011 Jul 19.

PMID:
21816220
22.

Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.

Pettazzoni P, Pizzimenti S, Toaldo C, Sotomayor P, Tagliavacca L, Liu S, Wang D, Minelli R, Ellis L, Atadja P, Ciamporcero E, Dianzani MU, Barrera G, Pili R.

Free Radic Biol Med. 2011 Jan 15;50(2):313-22. doi: 10.1016/j.freeradbiomed.2010.11.011. Epub 2010 Nov 13.

PMID:
21078383
23.

B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells.

Dianzani C, Minelli R, Mesturini R, Chiocchetti A, Barrera G, Boscolo S, Sarasso C, Gigliotti CL, Sblattero D, Yagi J, Rojo JM, Fantozzi R, Dianzani U.

J Immunol. 2010 Oct 1;185(7):3970-9. doi: 10.4049/jimmunol.0903269. Epub 2010 Sep 3.

24.

Can misdiagnosis in pre-operative FNAC of thyroid nodule influence surgical treatment?

Del Rio P, Minelli R, Cataldo S, Ceresini G, Robuschi G, Corcione L, Guazzi A, Nizzoli R, Sianesi M.

J Endocrinol Invest. 2011 May;34(5):345-8. doi: 10.3275/7140. Epub 2010 Jun 28.

PMID:
20588087
25.

Effect of serotonergic system on AVP secretion induced by physical exercise.

Coiro V, Maffei ML, Volta E, Cataldo S, Minelli R, Vacca P, Volpi R, Chiodera P.

Neuropeptides. 2010 Feb;44(1):53-6. doi: 10.1016/j.npep.2009.10.004. Epub 2009 Nov 14.

PMID:
19914713
26.

PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.

Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, Menegatti E, Daniela B, Minelli R, Giglioni B, Dianzani MU, Ferretti C, Barrera G.

J Cell Mol Med. 2010 Jun;14(6A):1347-57. doi: 10.1111/j.1582-4934.2009.00966.x. Epub 2009 Nov 13.

27.

4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity.

Pizzimenti S, Menegatti E, Berardi D, Toaldo C, Pettazzoni P, Minelli R, Giglioni B, Cerbone A, Dianzani MU, Ferretti C, Barrera G.

J Nutr Biochem. 2010 Sep;21(9):818-26. doi: 10.1016/j.jnutbio.2009.06.005. Epub 2009 Sep 3.

PMID:
19733043
28.

Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity.

Gentile F, Pizzimenti S, Arcaro A, Pettazzoni P, Minelli R, D'Angelo D, Mamone G, Ferranti P, Toaldo C, Cetrangolo G, Formisano S, Dianzani MU, Uchida K, Dianzani C, Barrera G.

Biochem J. 2009 Aug 13;422(2):285-94. doi: 10.1042/BJ20090564.

PMID:
19508232
29.

Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.

Rotondi M, Minelli R, Magri F, Leporati P, Romagnani P, Baroni MC, Delsignore R, Serio M, Chiovato L.

Eur J Endocrinol. 2007 Apr;156(4):409-14.

PMID:
17389454
30.

Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism.

Losa M, Mortini P, Minelli R, Giovanelli M.

J Endocrinol Invest. 2006 Jun;29(6):555-9.

PMID:
16840835
31.

Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection.

Minelli R, Coiro V, Valli MA, Finardi L, Di Seclì C, Bertoni R, La Gioia D, Barilli AL, Ferrari C, Jotti GS, Delsignore R.

J Investig Med. 2005 Jan;53(1):26-30.

PMID:
16025878
32.

Adrenocorticotropin/cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men.

Coiro V, Saccani-Jotti G, Minelli R, Melani A, Milli B, Manfredi G, Volpi R, Chiodera P.

Neuroendocrinology. 2005;81(2):103-6.

PMID:
15860925
33.

Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?

Minelli R, Valli MA, Di Seclì C, Finardi L, Chiodera P, Bertoni R, Ferrari C, Barilli AL, Coiro V, Saccani Jotti G, Delsignore R.

Horm Res. 2005;63(4):194-9. Epub 2005 Apr 28.

PMID:
15860921
34.

Maedi-visna virus detection in ovine third eyelids.

Capucchio MT, Sanna E, Sanna MP, Farigu S, Minelli R, Guarda F.

J Comp Pathol. 2003 Jul;129(1):37-43.

PMID:
12859906
35.

Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?

Bosi E, Minelli R, Bazzigaluppi E, Salvi M.

Diabet Med. 2001 Apr;18(4):329-32.

PMID:
11437866
36.

Thyroid hormone metabolism in obesity.

Roti E, Minelli R, Salvi M.

Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S113-5. Review.

PMID:
10997624
37.

Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.

Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, Roti E.

Eur J Endocrinol. 2000 Aug;143(2):197-202.

PMID:
10913938
38.

Expulsion of an artificial eye in a patient with thyroid-associated ophthalmopathy and surgical anophthalmos.

Salvi M, Spaggiari E, Neri F, Minelli R, Roti E.

Am J Med. 1999 Aug;107(2):191-2. No abstract available.

PMID:
10460062
39.

Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis.

Minelli R, Braverman LE, Valli MA, Schianchi C, Pedrazzoni M, Fiaccadori F, Salvi M, Magotti MG, Roti E.

Clin Endocrinol (Oxf). 1999 Jan;50(1):95-100.

PMID:
10341861
40.

Are thyroid function tests too frequently and inappropriately requested?

Roti E, Gardini E, Magotti MG, Pilla S, Minelli R, Salvi M, Monica C, Maestri D, Cencetti S, Braverman LE.

J Endocrinol Invest. 1999 Mar;22(3):184-90.

PMID:
10219885
41.

Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment.

Minelli R, Braverman LE, Giuberti T, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Roti E.

Clin Endocrinol (Oxf). 1997 Sep;47(3):357-61.

PMID:
9373459
42.

The study of visual evoked potentials in patients with thyroid-associated ophthalmopathy identifies asymptomatic optic nerve involvement.

Salvi M, Spaggiari E, Neri F, Macaluso C, Gardini E, Ferrozzi F, Minelli R, Wall JR, Roti E.

J Clin Endocrinol Metab. 1997 Apr;82(4):1027-30.

PMID:
9100568
43.

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.

Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Neri TM, Braverman LE.

Am J Med. 1996 Nov;101(5):482-7.

PMID:
8948271
44.

Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy.

Minelli R, Girasole G, Pedrazzoni M, Giuliani N, Schianchi C, Giuberti T, Braverman LE, Salvi M, Roti E.

J Investig Med. 1996 Aug;44(6):370-4.

PMID:
8795300
45.

Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.

Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E.

J Clin Endocrinol Metab. 1996 Aug;81(8):2976-9.

PMID:
8768861
46.

Clinical review 80: Management of hyperthyroidism and hypothyroidism in the pregnant woman.

Roti E, Minelli R, Salvi M.

J Clin Endocrinol Metab. 1996 May;81(5):1679-82. Review. No abstract available.

PMID:
8626813
47.

Circadian thyrotropin variations are preserved in normal pregnant women.

Roti E, Bartalena L, Minelli R, Salvi M, Gardini E, Pistolesi A, Martino E, Braverman LE.

Eur J Endocrinol. 1995 Jul;133(1):71-4.

PMID:
7627340
48.

Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease.

Salvi M, De Chiara F, Gardini E, Minelli R, Bianconi L, Alinovi A, Ricci R, Neri F, Tosi C, Roti E.

Eur J Endocrinol. 1994 Aug;131(2):113-9.

PMID:
8075779
49.

Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis.

Roti E, Bianconi L, De Chiara F, Minelli R, Tosi C, Gardini E, Salvi M, Braverman LE.

J Endocrinol Invest. 1994 Apr;17(4):259-62.

PMID:
7930377
50.

The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.

Roti E, Minelli R, Gardini E, Bianconi L, Salvi M, Gavaruzzi G, Ugolotti G, Braverman LE.

J Clin Endocrinol Metab. 1994 Mar;78(3):795-9.

PMID:
8126159

Supplemental Content

Loading ...
Support Center